Adenoid Cystic Carcinoma
Conditions
Interventions
Single-center, prospective study, which will be carried out in the Departments of Nuclear Medicine, Clinical Oncology and Head and Neck Surgery at the A.C.Camargo Cancer Center. It is estimated that a
V03.175.500
Sponsors
Eduardo Nóbrega Pereira Lima
Fundação Antônio Prudente - AC Camargo Cancer Center
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age above 18 years. Histological diagnostic confirmation of Neoplasia Adenoid Cystic Carcinoma (ADC). Ability to understand aspects associated with the proposed clinical study and consent to participate.Patients who have performed at least one onventional imaging (computed tomography, magnetic resonance imaging, ultrasonography, and bone scintigraphy) as part of an initial assessment of the extent of neoplastic disease or as part of a recent assessment of ongoing tumor response to CAdC neoplasia.
Exclusion criteria
Exclusion criteria: Clinical condition that contraindicates the use of targeted imaging for staging conventional or exposure to radiopharmaceuticals such as: ongoing pregnancy, breastfeeding or any condition that the attending physician considers a risk for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To present prospective controlled data on the use of PET/CT with 18F-PSMA in patients with CAD, using an isotope that is widely available in our routine, which may have a direct impact on the management of therapeutic | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes expected | — |
Countries
Brazil
Contacts
Public ContactAndre Ribeiro
AC Camargo Cancer Center
Outcome results
None listed